Skip to main content
SpringerLink
Log in
Book cover

Le dépistage du cancer du sein: un enjeu de santé publique pp 17–39Cite as

Histoire naturelle du cancer du sein

  • Chapter

  • 302 Accesses

Part of the book series: Dépistage et cancer ((DC))

Abstrait

Ľhistoire naturelle ďun type de cancer a pour objectif de reconstituer son évolution depuis sa naissance jusqu’à son émergence clinique, puis celle de ses métastases. Ľévénement le plus important de cette longue histoire est la dissémination métastatique à distance. En effet, aVan’t qu’elle ne survienne, le cancer est une maladie locorégionale curable par un traitement local: chirurgie ou radiothérapie; après qu’elle a eu lieu, le cancer est devenu une maladie généralisée dont le traitement est beaucoup plus aléatoire. Une caractéristique essentielle de ľhistoire naturelle Ďun type de cancer est donc la taille de la tumeur primitive au moment de la dissémination. Il faut également analyser les facteurs influençant cette taille, c’est-à-dire les facteurs pronostiques. Enfin, il faut considérer les étapes anatomiques de la dissémination métastatique, car les théories que ľon a pu avoir à leur sujet ont, depuis le XIXe siècle, influencé la stratégie thérapeutique.

This is a preview of subscription content, log in via an institution.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Tubiana M, Chauvel P, Renaud A (1975) Vitesse de croissance et histoire naturelle du cancer du sein. Bull Cancer 62: 341–58

    CAS  PubMed  Google Scholar 

  2. Koscielny S, Tubiana M, Le MG (1984) Breast cancer. Relationship between the size of the primary tumour and the probability of metastatic dissemination. Br J Cancer 49: 709–15

    CAS  PubMed  Google Scholar 

  3. Koscielny S, Tubiana M, Valleron AJ (1985) A simulation model of the natural history of human breast cancer. Br J Cancer 52: 515–24

    CAS  PubMed  Google Scholar 

  4. Atkinson EN, Brown BW, Montague ED (1986) Tumor volume, nodal status and metastasis in breast cancer women. J Nt Cancer Inst 76: 171–8

    CAS  Google Scholar 

  5. Tubiana M (1987) Histoire naturelle des cancers humains et facteurs pronostiques. Ľexemple du cancer du sein. Bull. Cancer (Paris) 74: 43–57

    CAS  Google Scholar 

  6. Koscielny S, Lê MG, Tubiana M (1989) The natural history of human breast cancer. The relationship between involvement of axillary lymph nodes and the intiation of distant metastases. Br J Cancer 59: 775–82

    CAS  PubMed  Google Scholar 

  7. Carter CL, Allen C, Herson DE (1989) Relation of tumor size, lymph node status and survival in 24,740 breast cancer cases. Cancer 63: 181–7

    Article  CAS  PubMed  Google Scholar 

  8. Tubiana M, Koscielny S (1991) Natural history of human breast cancer: Recent data and clinical implications. Breast Cancer Res Treat 18: 125–40

    Article  CAS  PubMed  Google Scholar 

  9. Koscielny S, Tubiana M (1999) The link between local recurrence and distant metastases in human breast cancer. Int J Radiat Oncol Biol Phys 43: 11–24 and 1999, 45: 245–6

    CAS  PubMed  Google Scholar 

  10. Kamby C et al. (1991) Pattern of spread and progression in relation to the characteristics of the primary tumour in human breast cancer. Acta Oncol 30: 301–8

    Article  CAS  PubMed  Google Scholar 

  11. Tubiana M, Koscielny S (1990) The Natural History of Breast Cancer. Implication for a Screening Strategy. Int J Radiat Oncol 19: 1117–20

    Article  CAS  Google Scholar 

  12. Tubiana M, Koscielny S (1999) The rationale for early diagnosis of cancer. The example of breast cancer. Acta Oncol 38: 295–303

    Article  CAS  PubMed  Google Scholar 

  13. Boyle P, Reake R (1988) Progress in understanding breast cancer. Epidemiological and biological interactions. Breast Cancer Res Treat 11: 91–112

    Article  CAS  PubMed  Google Scholar 

  14. Lalanne CM (1963) Taux ďaccroissement et pronostic des tumeurs malignes du sein. In: P Denoix, C Rouquette (eds). Symposium on the prognosis of malignant tumours of the breast. Karger, Ed. Basel, pp. 16–23

    Google Scholar 

  15. Slack NH, Blumenson LE, Bross IDJ (1969) Therapeutic implications of a mathematic model caracterizing the course of breast cancer. Cancer 24: 960–71

    Article  CAS  PubMed  Google Scholar 

  16. Charbit A, Malaise E, Tubiana M (1971) Relation between the pathological nature and the growth rate of human tumors. Eur J Cancer 7: 307–15

    CAS  PubMed  Google Scholar 

  17. Kusama S et al. (1972) The gross rates of growth of human mammary carcinoma Cancer 30: 594–9

    Article  CAS  PubMed  Google Scholar 

  18. Malaise EP et al. (1974) Relationship between the growth rate of human metastases, suvival and pathological type. Eur J Cancer 10: 451–9

    CAS  PubMed  Google Scholar 

  19. Malaise EP, Chavaudra N, Tubiana M (1973) The relationship between growth rate, labelling index and histological type of human solid tumours. Eur J Cancer 9: 305–12

    CAS  PubMed  Google Scholar 

  20. Contesso G et al. (1987) The importance of histologic grade in long-term pronosis of breast cancer. À study of 1,010 patients, uniformly treated, at the Institut Gustave Roussy. J Clin Oncol 5: 1378–86

    CAS  PubMed  Google Scholar 

  21. Contesso G, Saccanijotti G, Bonadonna G (1989) Tumor grade as a pronostic factor in primary cancer. Eur J Cancer Clin Oncol 25: 403–9

    Article  CAS  PubMed  Google Scholar 

  22. McGuire WL (1987) Prognosis factors for recurrence and survival in human breast cancer. Breast Cancer Res Treat 10: 5–9

    Article  CAS  PubMed  Google Scholar 

  23. Tagnon HJ (1986) Changing concepts of the natural history of human mammary cancer and their effects on diagnosis and treatment. Eur J Cancer Clin Oncol 22: 123–8

    Article  CAS  PubMed  Google Scholar 

  24. Tabar L et al. (1992) Breast cancer treatment and natural history: New insights from results of screening. Lancet 339: 412–4

    Article  CAS  PubMed  Google Scholar 

  25. Tubiana M, Koscielny S (2001) The natural history of breast cancer and the link between local recurrence and distant metastases: Implications for therapy. Rep Pract Oncol Radiother 6: 181–95

    Google Scholar 

  26. Romddahl MS et al. (1961) The time of metastasis and release of circulating tumor cells as determined in an experimental system. Cancer 14: 883–8

    Article  Google Scholar 

  27. Fortin A et al. (1999) Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy. J Clin Oncol 17: 101–9

    CAS  PubMed  Google Scholar 

  28. Tubiana M et al. (1989) Growth rate, kinetics of tumor cell proliferation and long-term outcome in human breast cancer. Int J Cancer 44: 17–22

    Article  CAS  PubMed  Google Scholar 

  29. Clarke R et al. (1989) Progression of human breast cancer cells from hormonal dependent to independent growth both in vitro and in vivo. Proc Nat Acad Sc USA 86: 3649–53

    Article  CAS  Google Scholar 

  30. Meyer et al. (1986) Breast carcinoma cell kinetics, morphology, stage and host characteristics: A thymidine labelling study. Lab Invest 54: 41–51

    CAS  PubMed  Google Scholar 

  31. Silvestrini R, Daidone MG, Di Fronzo G (1979) Relationship between proliferative activity and estrogen receptors in breast cancer. Cancer 44: 665–70

    Article  Google Scholar 

  32. Silvestrini R et al. (1986) Prognostic implication of labelling index versus estrogen receptors and tumor size in node negative breast cancer. Breast Cancer Res Treat, 7: 161–9

    Article  CAS  PubMed  Google Scholar 

  33. Tubiana M, Courdi A (1989) Cell proliferation kinetics in human solid tumors: Relation to probability of metastatic dissemination and long-term survival. Radiother Oncol 15: 1–18

    Article  CAS  PubMed  Google Scholar 

  34. Dressler LG et al. (1988) DNA flow cytometry and prognostic factors in 1,331 frozen breast cancer specimens. Cancer 61: 420–7

    Article  CAS  PubMed  Google Scholar 

  35. Tubiana M, Arriagada R, Sarrazin D (1986). Human cancer natural history. Radiation induced immunodepression and post-operative radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 2: 477–85

    Google Scholar 

  36. Clarke R, Brunner N, Thompson EW et al. (1989) Progression of human breast cancer cells from hormonal dependent to independent growth both in vitro and in vivo. Proc Nat Acad Sci USA. 86: 3649–53

    Article  CAS  PubMed  Google Scholar 

  37. Tubiana M, Péjovic MH, Koscielny S et al. (1989) Growth rate, kinectics of tumor cell proliferation and long-term outcome in human breast cancer. Int. J. Cancer. 44: 17–22

    Article  CAS  PubMed  Google Scholar 

  38. Van’t Veer LJ, Dai H, van de Vijver MJ (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature. 415: 530–6

    Article  Google Scholar 

  39. Van de Vijver MJ, He YD, Van’t Veer LJ et al. (2002) A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347: 1999–2009

    Article  PubMed  Google Scholar 

  40. Weiglt B, Perterse JL, Van’t Veer L.J (2005) Breast cancer metastasis: markers and models. Nature Reviews Cancer. 5: 591–602

    Article  Google Scholar 

  41. Wallgren A (2000) AdjuVan’t radiotherapy after breast conserving surgery for breast cancer. Contra. Eur J Cancer. 36: 1078–82

    Article  CAS  Google Scholar 

  42. Michiels S, Koscielny S, Hill C (2005) Prediction of cancer outcome with microarrays: a multiple validation strategy. Lancet. 365: 488–92

    Article  CAS  PubMed  Google Scholar 

  43. Sternsward J (1974) Decreased survival related to irradiation post-operatively in early operable breast cancer. Lancet 2: 1285–6

    Article  Google Scholar 

  44. Whelan TJ, Julian J, Wright J et al. (2000) Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol. 18: 1220–9

    CAS  PubMed  Google Scholar 

  45. Sauer R (2000) AdjuVan’t radiotherapy after breast conserving surgery for breast cancer. Eur J Cancer. 36: 1073–8

    Article  CAS  PubMed  Google Scholar 

  46. Tubiana M, Koscielny S (2005) Ľhistoire natuelle du cancer du sein. Implication par le dépistage et le traitement. Bull. Mem. Acad. Roy. Méd. Belg. 160: 367–84

    CAS  Google Scholar 

  47. Michaelson JS, Cheongsiatmoy JA, Dewey F et al. (2005) Spread of human cancer cells occurs with probabilities indicative of a nongenetic mechanism. Brit. J. Cancer. 93: 1244–9

    Article  CAS  PubMed  Google Scholar 

  48. Fidler IJ, Kripke ML (1977) Metastatic results from preexisting vriant cells within a malignant tumor. Science. 197: 893–5

    Article  CAS  PubMed  Google Scholar 

  49. Bjerkvig R, Tynes BB, Aboody KS et al. (2005) Opinion: the origin of the cancer stem cell: current controversies and new insights. Nature Reviews/Cancer. 5: 899–904

    Article  CAS  Google Scholar 

  50. Huntly BHP, Gilliland DG (2005) Leukemia stem cells and the evolution of cancer stem cell research. Nature Reviews/Cancer. 5: 311–21

    Article  CAS  Google Scholar 

  51. The Swedish Organised Service Screening Evaluation Group (2006). Reduction in breast cancer mortality from Organized Service Screening with mammography: 1. Further confirmation with extended data. 15: 45–51 et 52–56

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. ľinstitut Gustave-Roussy, Villejuif

    M. Tubiana (Directeur honoraire)

  2. ľinstitut Gustave-Roussy, Villejuif

    S. Koscielny (Docteur ès science, biostatisticien)

Authors
  1. M. Tubiana
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Koscielny
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Veralg France, Paris

About this chapter

Cite this chapter

Tubiana, M., Koscielny, S. (2007). Histoire naturelle du cancer du sein. In: Le dépistage du cancer du sein: un enjeu de santé publique. Dépistage et cancer. Springer, Paris. https://doi.org/10.1007/978-2-287-39695-3_1

Download citation

  • DOI: https://doi.org/10.1007/978-2-287-39695-3_1

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-39694-6

  • Online ISBN: 978-2-287-39695-3

Publish with us

Policies and ethics

Search

Navigation